Clinical trial

Prevention of P. Vivax Malaria During Pregnancy in Bolivia

NCT00290420 · Institut de Recherche pour le Developpement, Other · Withdrawn

Key facts

NCT number NCT00290420
Title Prevention of P. Vivax Malaria During Pregnancy in Bolivia
Official title Prevention of P. Vivax Malaria During Pregnancy: Effects on Mother and Child Health in Santa Cruz, Bolivia. Open, Multicentric, Randomized Clinical Trial, Comparing Prophylaxis Once a Week to Malaria Attack Treatment, Both by Chloroquine.
Lead sponsor Institut de Recherche pour le Developpement, Other
Collaborators Instituto Nacional de Laboratorios de Salud (INLASA) Pan American Health Organization Ministry of Health, Bolivia
Status Withdrawn
Phase Phase 4
Study type Interventional
Conditions Malaria
Intervention type Drug
Interventions Chloroquine profilaxis
Enrollment 0
Start date Mar 1, 2006
Primary completion Nov 1, 2007
Completion Nov 1, 2007
First posted Feb 13, 2006
Last update posted May 22, 2013

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies